Clinical Trial Update: AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 1/2 clinical trial evaluating AMG 102 in combination with mitoxantrone and prednisone in men with previously treate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• AMG 102 (AMG 102)
• Mitoxantrone (mitoxantrone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Amgen | Conditions: Cancer, Castrate-Resistant Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED